Target/Product
Indications
Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Partner

Single agent: gastric, biliary & pancreatic cancer

Combination with anti-PD-1: melanoma

Colorectal cancer

AZ Collaboration

Not disclosed

Not disclosed

Target/Product
Indications

Single agent: gastric, biliary & pancreatic cancer

Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications

Combination with anti-PD-1: melanoma

Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications

Colorectal cancer

Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications
AZ Collaboration

Not disclosed

Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications

Not disclosed

Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications
Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications
Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I
Target/Product
Indications
Lead Generation
Lead Optimisation
CTA/ IND-enabling
Phase I